307 related articles for article (PubMed ID: 24715215)
1. Prognostic significance of p21-activated kinase 6 expression in patients with clear cell renal cell carcinoma.
Liu W; Liu H; Liu Y; Xu L; Zhang W; Zhu Y; Xu J; Gu J
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S575-83. PubMed ID: 24715215
[TBL] [Abstract][Full Text] [Related]
2. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
[TBL] [Abstract][Full Text] [Related]
3. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
4. p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma.
Zhu Y; Xu L; An H; Liu W; Wang Z; Xu J
Int J Urol; 2015 May; 22(5):447-53. PubMed ID: 25711487
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.
An H; Zhu Y; Xie H; Liu Y; Liu W; Fu Q; Ye D; Xu J
Tumour Biol; 2016 Apr; 37(4):4523-9. PubMed ID: 26503211
[TBL] [Abstract][Full Text] [Related]
6. GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma.
Liu Y; Liu W; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
J Urol; 2014 Nov; 192(5):1534-41. PubMed ID: 24769034
[TBL] [Abstract][Full Text] [Related]
7. Notch1 predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.
An H; Zhu Y; Xu L; Chen L; Lin Z; Xu J
Urology; 2015 Feb; 85(2):483.e9-483.e14. PubMed ID: 25559729
[TBL] [Abstract][Full Text] [Related]
8. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
9. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.
Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J
Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266
[TBL] [Abstract][Full Text] [Related]
10. High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Liu W; Liu Y; Fu Q; Xu J
Cancer Sci; 2015 May; 106(5):592-7. PubMed ID: 25702890
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of intratumoral C-reactive protein expression in patients with clear cell renal cell carcinoma.
Can C; Acikalin MF; Ozen A; Dundar E
Urol Int; 2014; 92(3):270-5. PubMed ID: 24356040
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
[TBL] [Abstract][Full Text] [Related]
13. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma.
Yang L; Wu Q; Xu L; Zhang W; Zhu Y; Liu H; Xu J; Gu J
BMC Cancer; 2015 Feb; 15():67. PubMed ID: 25886010
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma.
Teng J; Gao Y; Chen M; Wang K; Cui X; Liu Y; Xu D
Chin Med J (Engl); 2014; 127(9):1640-4. PubMed ID: 24791867
[TBL] [Abstract][Full Text] [Related]
17. High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma.
Xiong Y; Liu L; Xia Y; Wang J; Xi W; Bai Q; Qu Y; Long Q; Xu J; Guo J
Oncotarget; 2016 Sep; 7(39):63661-63668. PubMed ID: 27564117
[TBL] [Abstract][Full Text] [Related]
18. The Presence of Vascular Mimicry Predicts High Risk of Clear Cell Renal Cell Carcinoma after Radical Nephrectomy.
Zhou L; Chang Y; Xu L; Liu Z; Fu Q; Yang Y; Lin Z; Xu J
J Urol; 2016 Aug; 196(2):335-42. PubMed ID: 26970566
[TBL] [Abstract][Full Text] [Related]
19. Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.
Fu H; Liu Y; Xu L; Liu W; Fu Q; Liu H; Zhang W; Xu J
Tumour Biol; 2015 Aug; 36(8):5791-9. PubMed ID: 25716202
[TBL] [Abstract][Full Text] [Related]
20. High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma.
Liu Y; Yang L; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
Sci Rep; 2015 Nov; 5():16954. PubMed ID: 26599282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]